NCT00263575View on ClinicalTrials.gov

Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

December 31, 2005

Primary Completion Date

December 31, 2008

Study Completion Date

January 31, 2009

Conditions
PainCancer
Interventions
DRUG

EN3267

EN3267 will be available in 100, 200, 300, 400, 600 (two 300 ug tablets), and 800 ug (two 400 ug tablets) doses

Trial Locations (1)

27103

Carolinas Pain Institute, Winston-Salem

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT00263575 - Long-term Safety Study of Sublingual Fentanyl Tablets in Cancer Patients | Biotech Hunter | Biotech Hunter